Efficient base determination in sequencing reactions

• US 8,551,702 B2
• Filed: 12/15/2008
• Issued: 10/08/2013
• Est. Priority Date: 11/05/2007
• Status: Active Grant

• Current Assignee: Complete Genomics Incorporated (BGI Genomics Co., Ltd.)
• Original Assignee: Complete Genomics Incorporated (BGI Genomics Co., Ltd.)
• Inventors: Drmanac, Radoje, Callow, Matthew
• Primary Examiner(s): Bhat, Narayan
• Application Number:
  US12/335,188
• Publication Number:
  US 20090176234A1
• Time in Patent Office: 1,758 Days
• Field of Search: 435/4, 435/6.1, 435/6.11, 435/6.12, 435/91.2, 435/91.4, 435/193, 435/287.2, 536/23.1, 536/24.2, 536/24.3
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/6855 Ligating adaptors
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2521/125 Methyl transferase, i.e. methylase
• CPC Class Codes: C12Q 2521/313 Type II endonucleases, i.e. cutting outside recognition site
• CPC Class Codes: C12Q 2521/501 Ligase
• CPC Class Codes: C12Q 2521/531 Glycosylase
• CPC Class Codes: C12Q 2525/151 repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
• CPC Class Codes: C12Q 2525/191 incorporating an adaptor
• CPC Class Codes: C12Q 2525/307 Circular oligonucleotides
• CPC Class Codes: C12Q 2531/125 Rolling circle
• CPC Class Codes: C12Q 2537/163 blocking probe

Abstract

The present invention is directed to compositions and methods for nucleic acid identification and detection. Compositions and methods of the present invention include extracting and fragmenting target nucleic acids from a sample, using the fragmented target nucleic acids to produce target nucleic acid templates and subjecting those target nucleic acid templates to amplification methods to form nucleic acid nanoballs. The invention also includes methods of detecting and identifying sequences using various sequencing applications, including sequencing by ligation methods.

Claims

1. A method for identifying a nucleotide at a target detection position of a target sequence comprising a plurality of detection positions, said method comprising:

(a) providing a surface comprising a plurality of concatemers, wherein each concatemer comprises a plurality of monomers and each monomer comprises;

i) a target domain of said target sequence comprising a first set of target detection positions;

ii) a first adaptor comprising an anchor site;

b) hybridizing a first anchor probe to said anchor site;

c) hybridizing a second anchor probe to a hybridization site that is between the first anchor site and the target domain and contiguous with both, wherein the second anchor probe is fully degenerate and the hybridization site is in the target sequence and;

d) hybridizing a sequencing probe to said first target domain, wherein said sequencing probe comprises;

i) a probe domain complementary to said target domain, wherein said probe domain includes a unique nucleotide at an interrogation position; and

ii) a label;

under conditions wherein, if said unique nucleotide is complementary to a nucleotide at a target detection position, said sequencing probe hybridizes to said concatemer;

e) ligating said anchor probes and said sequencing probe to form a probe ligation product; and

then

f) detecting said probe ligation product, thereby identifying said nucleotide.

2. The method according to claim 1 wherein a set of sequencing probes are contacted with said surface, each sequencing probe comprising:

a) a first probe domain complementary to said target domain;

b) a unique nucleotide at a first interrogation position; and

c) a label;

wherein each label of said set corresponds to said unique nucleotide.

3. The method according to claim 1 wherein each of said monomers comprises a plurality of adaptors.

4. The method according to claim 3 wherein at least one of said adaptors comprises at least one Type IIs endonuclease recognition site.

5. The method according to claim 1 wherein steps b)-e) are repeated for multiple cycles to identify nucleotides at additional target detection positions in said first set of target detection positions, wherein in different cycles different sequencing probes are used, wherein said different sequencing probes differ by having a unique nucleotide at different interrogation positions.

6. The method according to claim 5 wherein in at least some cycles, in step b) the first anchor probe is not phosphorylated at the 5′

terminus and in step c) the second anchor probe is phosphorylated at the 5′ and

3′

termini.

7. The method according to claim 6 wherein in at least some cycles, in step b) the first anchor probe is phosphorylated at its 5′

terminus and the second anchor probe is not phosphorylated at its 5′ and

3′

termini.

8. The method according to claim 5 wherein in at least some cycles, in step b) the first anchor probe is phosphorylated at its 5′

terminus and the second anchor probe is not phosphorylated at its 5′ and

3′

termini.

9. The method according to claim 1, wherein said second anchor probe comprises at least one terminus that is selectively activatable for ligation.

10. The method according to claim 1 wherein said surface is functionalized.

11. The method according to claim 10 wherein said functionalized surface comprises functional moieties selected from the group consisting of amines, silanes, and hydroxyls.

12. The method according to claim 1 wherein said surface comprises a plurality of spatially distinct regions comprising said immobilized concatemers.

13. The method according to claim 1 wherein said concatemers are immobilized on said surface using capture probes.

14. The method according to claim 1 further comprising fragmenting genomic nucleic acid to form target sequences.

15. The method according to claim 1 wherein said target sequence is a genomic nucleic acid sequence.

16. The method according to claim 15 wherein said genomic nucleic acid sequences are human.

17. The method according to claim 1 wherein the first anchor probe is not phosphorylated at the 5′

terminus and the second anchor probe is phosphorylated at the 5′ and

3′

termini.

18. The method according to claim 1 wherein the first anchor probe is phosphorylated at its 5′

terminus and the second anchor probe is not phosphorylated at its 5′ and

3′

termini.

19. The method according to claim 1 wherein the first and second anchor probes are ligated together in first step to form an extended anchor, and in a separate subsequent step the sequencing probe is ligated to the extended anchor to form the probe ligation product.

20. The method according to claim 19 wherein after said first step and before said subsequent step the extended anchor is de-phosphorylated at its 3′

terminus.

21. The method according to claim 20 wherein the extended anchor is dephosphorylated by the action of T4 DNA kinase.

22. The method according to claim 1 wherein the first and second anchor probes are ligated together in first step to form an extended anchor with a phosphorylated 5′

terminus, and in a separate subsequent step the sequencing probe is ligated to the extended anchor to form the probe ligation product.

23. The method according to claim 1 wherein the first and second anchor probes are ligated together in first step to form an extended anchor with a non-phosphorylated 5′

terminus, and in a separate subsequent step the sequencing probe is ligated to the extended anchor to form the probe ligation product.

24. The method according to claim 23 wherein after said first step and before said subsequent step the extended anchor is phosphorylated at its 5′

terminus.

25. The method according to claim 24 wherein the extended anchor is phosphorylated by the action of T4 DNA kinase.

26. The method according to claim 1 wherein the second anchor probe is 5 to 20 bases in length.

27. The method according to claim 1, wherein step c) comprises hybridizing two or more second anchor probes to said hybridization site, wherein said two or more second anchor probes are fully degenerate.

28. The method according to claim 27 wherein step c) comprises hybridizing two second anchor probes to said hybridization site.

29. The method according to claim 27 wherein each of the second anchor probes is 5 to 20 bases in length.